19 December 2018

Responding to NICE final guidance that three tumour profiling tests will be available to guide adjuvant chemotherapy decisions in people with early breast cancer, Dr Emma Pennery, Clinical Director at Breast Cancer Care, says:

“This important decision means access to life-changing tumour profiling tests is now set in stone. Thousands of women with breast cancer in England could safely avoid enduring chemotherapy and its utterly devastating, often long-lasting, side effects – including hair loss, fatigue and problems with fertility.

“These tests will give both clinicians and women with breast cancer more confidence to know they are making the right treatment decision for them.

“Approving a selection of profiling tests indicates a bright future for increasingly tailored treatments for individuals. With more and more women living longer after breast cancer, we must ensure that treatment is not only successful, but allows women to live well.”

-Ends-

For further information, please contact:

Sophie Softley Pierce, Breast Cancer Care

07702 901 334; sophie.pierce@breastcancercare.org.uk

About Breast Cancer Care

Breast Cancer Care is the only specialist UK wide charity providing support for women, men, family and friends affected by breast cancer. We’ve been caring for them, supporting them, and campaigning on their behalf since 1973.

Today, we continue to offer a unique range of support including reliable information, one-to-one support over the phone and online from nurses and people who’ve been there. We also offer local group support across the UK.

From the moment someone notices something isn’t right, through to their treatment and beyond, we’re there to help people affected by breast cancer feel more in control. breastcancernow.org